Although there were some confounding variables between the subjects, including the treatment status of HER2-targeted or hormonal therapy, cancer patients with hyperglycemic episodes had significantly higher NOTCH activity based on immunofluorescence staining of nuclear NOTCH1 (Fig. 6h, i). The gene discussed is NOTCH1; the disease is cancer.